Greenbrook TMS (TSX: GTMS) (OTC: GBOKF) Attends 31st Annual ROTH Conference
Greenbrook TMS (TSX: GTMS) (OTC: GBOKF) is a provider of TMS, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Operating through 59 company-operated treatment centers, Greenbrook has provided more than 200,000 TMS treatments to over 5,700 patients struggling with depression. For more information, visit the company's website at www.greenbrooktms.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire…
